MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.Published in:2012Publication type:Abstract
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.Published in:2012Publication type:Abstract
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.Published in:2012Publication type:Abstract
Inflammatory cortical demyelination in early multiple sclerosis.Published in:2012Publication type:Abstract
Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.Published in:2012Publication type:Abstract
Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis.Published in:2012Publication type:Abstract
Regional brain atrophy in children with multiple sclerosis.Published in:2012Publication type:Abstract
Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies.Published in:2012Publication type:Abstract
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.Published in:2012Publication type:Abstract
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.Published in:2012Publication type:Abstract
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study.Published in:2012Publication type:Abstract
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.Published in:2012Publication type:Abstract
Circulating CD8<sup>+</sup>CD56-perforin<sup>+</sup> T cells are increased in multiple sclerosis patients.Published in:2012Publication type:Abstract
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).Published in:2012Publication type:Abstract
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.Published in:2012Publication type:Abstract
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.Published in:2012Publication type:Abstract
Ocrelizumab in relapsing-remitting multiple sclerosis: a Phase 2, randomised, placebo-controlled, multicentre trial.Published in:2012Publication type:Abstract
The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.Published in:2012Publication type:Abstract
Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.Published in:2012Publication type:Abstract
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a Phase 3 randomised controlled trial.Published in:2012Publication type:Abstract
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.Published in:2012Publication type:Abstract
Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity.Published in:2012Publication type:Abstract
Firategrast for relapsing remitting multiple sclerosis: a Phase 2, randomised, double-blind, placebo-controlled trial.Published in:2012Publication type:Abstract
Sudden cardiac death in multiple sclerosis caused by active demyelination of the medulla oblongata.Published in:2012Publication type:Abstract
Functional MRI, Diffusion Tensor Imaging, and MR Spectroscopy of the Spinal Cord in Multiple Sclerosis.Published in:Current Medical Literature: Multiple Sclerosis, 2012, v. 4, n. 1, p. 1Publication type:Article
Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.Published in:2012Publication type:Abstract
Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis.Published in:2012Publication type:Abstract
Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis.Published in:2012Publication type:Abstract
Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis.Published in:2012Publication type:Abstract
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.Published in:2012Publication type:Abstract
Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis.Published in:2012Publication type:Abstract
Foreword.Published in:Current Medical Literature: Multiple Sclerosis, 2012, v. 4, n. 1, p. 1Publication type:Article